This work was supported by the VA Merit Review #I01 BX000760 (RFK) from the United States (U.S.) Department of Veterans Affairs BLR&#38;D and U.S. Department of Veterans Affairs grant #I01 BX004146 (TAB). We also gratefully acknowledge the support of the University of Minnesota Lillehei Heart Institute. The contents of this work do not represent the views of the U.S. Department of Veterans Affairs of the United States Government.

The Institutional Animal Care and Use Committees (IACUC) of the Minneapolis VA Medical Center and the University of Minnesota have approved all of the animal studies. The current National Institutes of Health (NIH) guidelines for the use and care of laboratory animals were followed.
1. Isolation of mesenchymal stem cells and preparation and characterization of exosomes
<ol>
	<li>Isolation of bone marrow derived mesenchymal stem cells (MSCs)
	<ol>
		<li>Obtain 30-50 mL of sterile bone marrow from the sternum or tibia of a 20-week-old female Yorkshire-Landrace swine. To do this, introduce a 25 mm 15G interosseous needle into the sternum or tibia and draw the sample into a 60 mL syringe with 10 mL of heparin. 
		NOTE: For further details on the collection of bone marrow refer to Pittenger et al. and Hocum-Stone et al.12,16.</li>
		<li>In brief, pass the bone marrow specimen through a Vacutainer&#160;CPT tube with heparin for 30 min at 1800 x&#160;g.</li>
		<li>Remove the buffy coat containing the mononuclear cells and wash with Hank&#39;s balanced salt solution. Pellet mononuclear cells by centrifugation and resuspend in growth medium (10% fetal bovine serum [FBS]).</li>
		<li>Transfer the mononuclear cells to cell culture flasks for adherent growth. Isolate the MSCs from the mononuclear fraction by their adherent nature.</li>
		<li>Wash all non-MSCs within 24 h, leaving a monolayer of MSCs in the tissue culture flask. Confirm the MSC phenotype by flow cytometry, ensuring negativity for CD45, a hematopoietic marker, and positivity for CD90 and CD105, markers of MSCs.</li>
	</ol>
	</li>
	<li>Preparation and characterization of exosomes from porcine mesenchymal stem cells
	<ol>
		<li>Seed 1 x 104 H9C2 rat cardiomyocytes and culture in 1x DMEM+ 10% FBS and 1x Pen/strep. Seed 2 x 104 porcine MSCs in advanced DMEM&#160;+ 5% FBS and 1x Pen/strep.</li>
		<li>Once both cell lines are at least 80% confluent, change the media to exosome depleted H9C2 and MSC media.</li>
		<li>Expose H9C2 cardiomyocytes to mild hypoxia (1% O2 for 24 h). Remove flasks from hypoxia after 24 h and pipette out H9C2 media.</li>
		<li>Remove and discard the MSC media from MSC flask. Add purified H9C2 media to MSC flask. Incubate the flask for 6 h in normoxic conditions (5% CO2, 20% O2, and 37 &#176;C).</li>
		<li>Extract the exosomes from the co-cultured conditioned media using the total exosome isolation reagent following manufacturer&#39;s instructions.</li>
		<li>Verify the identification of exosomes by western blot detection of common exosomal proteins with antibodies against CD-63 (1:1000)17.</li>
		<li>Perform nanoparticle tracking analysis (NTA) to quantify the exosomes and the assessment of nanoparticle size and its distribution. To do this, dissolve total protein (50 &#956;g) of exosomes in 500 &#956;L of PBS to determine the concentration and size distribution of exosomes by using nanoparticle tracking analyzer.</li>
		<li>Analyze the data using nanoparticle tracking software.</li>
	</ol>
	</li>
</ol>
2. Off pump coronary artery bypass graft surgery
<ol>
	<li>Animal preparation
	<ol>
		<li>Weigh the animal (16-week-old female Yorkshire-Landrace pigs) 3 days before scheduled for surgery. Fast the animal for 12 h before surgery while having access to water during fasting.</li>
		<li>Give buprenorphine 0.18 mg/kg via intramuscular route 2-4 h before surgery.</li>
	</ol>
	</li>
	<li>Induction of the animal
	<ol>
		<li>Sedate the animal by giving intramuscular injection of 6.6 mg/kg tiletamine-zolazepam/xylazine.</li>
		<li>Wait for 15 min to ensure adequate sedation by assessing the jaw tone followed by 22G catheter placement in the central ear vein. 
		NOTE: Another peripheral vein may be considered (i.e., cephalic vein) if ear vein is inadequate.</li>
		<li>Administer ophthalmic ointment topically to each eye. Administer 1-2 mg/kg of propofol via intravenous route to induce general anesthesia. Jaw tone most reliably reflects the depth of anesthesia and should be assessed throughout the procedure.</li>
		<li>Intubate the animal with an endotracheal tube of appropriate size.</li>
	</ol>
	</li>
	<li>Surgery
	<ol>
		<li>Shave the sternum and groin of the animal in preparation for surgical procedure.</li>
		<li>Set mechanical ventilation at 10-15 breaths per min, oxygen 1-4 L/min, and isoflurane 1.0-3.0% as needed to maintain deep anesthesia for surgery. Check for absent eye or jaw reflex to confirm deep anesthesia.</li>
		<li>Position monitoring equipment (Electrocardiogram, end tidal CO2, heart rate, Oxygen saturation, blood pressure, and temperature) on the animal.</li>
		<li>Connect the IV catheter to a bag of normal saline or lactate ringers&#39; solution to administer maintenance fluids continuously.</li>
		<li>Prepare the skin using aseptic technique with povidone Iodine scrub and solution 3x for adequate sterility and to minimize the risk of surgical site infection.</li>
		<li>Give Lidocaine via intravascular route (loading dose of 2 mg/kg or continuous infusion at dose of 50 mcg/kg/min) to prevent arrhythmias.</li>
		<li>Position the animal dorsally and drape with sterile towels.</li>
		<li>Perform either left or right femoral artery cut down for arterial line placement by Seldinger technique followed by connecting the catheter to the transducer for continuous blood pressure monitoring at the time of surgery.</li>
		<li>Use monopolar electrocautery to make a 20 cm incision extending from the sternal notch proximally down to the xyphoid process distally, and to incise layers of muscles, subcutaneous fat, and connective tissue down to the sternum.</li>
		<li>Perform median sternotomy by using oscillating saw. 
		NOTE: Standard saw is avoided for repeat sternotomy as it carries higher risk for myocardial injury from previous pericardial adhesions from left thoracotomy procedure done to place the LAD constrictor.</li>
		<li>Divide the posterior sternal plate using a pair of scissors. Use a specialized chest retractor for adequate visualization of the mediastinum.</li>
		<li>Dissect adhesions using either monopolar electrocautery or the Metzenbaum scissors. Carefully dissect the peristernal muscle and fat to expose the left internal mammary artery (LIMA).</li>
		<li>Once LIMA is exposed lateral to the sternal edge, gently separate it from the chest wall using blunt dissection with electrocautery tip. Use the LIMA as a skeletonized graft.</li>
		<li>Start dissection at the level of 3rd intercostal space. Gently elevate the left sternal border for optimal visualization.</li>
		<li>Use gentle traction on the adventitia to expose the arterial and venous branches of LIMA. Clip the LIMA side of the branches using hemoclips and cauterize the chest wall side of the branches. 
		NOTE: Care must be taken not to cauterize the clip on the LIMA, because this may cause conduit narrowing.</li>
		<li>Once an initial segment of LIMA has been mobilized, continue the dissection proximally toward the level of subclavian vein and distally until the LIMA bifurcation.</li>
		<li>Once dissection is finished, administer heparin via intravenous route at a dose of 100-300 U/kg. Wait for 3 min after the heparin is administered.</li>
		<li>After 3 min, clip the distal end of the LIMA, just before the level of the LIMA bifurcation, and divide the conduit. Sew the distal end with a free 2-0 silk suture tie.</li>
		<li>Prepare the proximal end for grafting. Inspect the flow quality visually by letting the graft bleed for a few seconds.</li>
		<li>Gently clamp the distal end of LIMA conduit with an atraumatic bulldog clamp to avoid bleeding. Open the pericardium with an inverted-T making an approximately 5-6 cm incision. Place 3-0 size sutures on the pericardium for traction at both sides of the slit.</li>
		<li>Stabilize the LAD with silicone retraction tapes and tissue stabilizer, which is secured to the sternal retractor. Make an arteriotomy in LAD artery distal to the stenosis (caused by constrictor band) with an 11-blade and extend with an iris scissors.</li>
		<li>Place an appropriately sized coronary shunt in the LAD. Perform the LIMA to LAD anastomosis with 7-0 running non-absorbable suture using an off-pump bypass technique. Release the bulldog occluder on the LIMA and confirm the hemostasis.</li>
	</ol>
	</li>
	<li>Preparation of Mesenchymal Stem Cell (MSC)-derived exosome patch
	<ol>
		<li>Following successful isolation of exosomes from MSCs, suspend roughly 3 x 108 exosomes in 3 mL of normal saline and add to collagen sponge.</li>
		<li>Bring 3 mL of exosome suspension to room temperature at around 22 &#176;C for 10 min. Place 2 absorbable collage sponges (each 1.27 cm x 2.54 cm) into a medium Petri dish.</li>
		<li>Use a 5 mL syringe with an 18G needle to gently mix exosome suspension. Slowly pipette 1.5 mL suspension onto each collagen sponge and wait for 5 min for full absorption.</li>
	</ol>
	</li>
	<li>Placement of exosome patch
	<ol>
		<li>Place the Exosome-laden sponge upside down onto the hibernating region of the heart, which is the epicardium of the anterior septal region in the distribution of the LAD.</li>
		<li>Gently place two sponges to cover the hibernating region of the heart. Use one 3.5 cm x 1.0 cm polyglactin mesh to cover each collagen sponge.</li>
		<li>Sew the mesh onto the epicardium with fine 7-0 interrupted sutures.</li>
	</ol>
	</li>
	<li>Chest tube placement
	<ol>
		<li>Place a chest tube through separate stab incision, near the inferior aspect of the sternotomy incision. Place the chest tube cautiously over the anterior aspect of the heart.</li>
		<li>Once the tube is in place, place a purse string suture with 3-0 suture using a horizontal mattress stitch to allow for closure of the wound upon removal of the tube.</li>
		<li>The chest tube is maintained until complete chest closure.</li>
	</ol>
	</li>
	<li>Chest closure
	<ol>
		<li>Approximate the sternum with non-absorbable sutures using a figure eight pattern. Administer 1 mg/kg bupivacaine via intramuscular route along the entire length of the incision. 
		NOTE: Suture is used rather than wires to avoid interference with MRI imaging.</li>
		<li>Close layers of muscle and skin in the standard fashion using 2-0 and 3-0 absorbable suture, respectively.</li>
		<li>Perform a breath hold and suction to evacuate all the air out of the thoracic cavity. Monitor the airway pressure on the ventilator cautiously and maintain the pressure between 15-22 mmHg and release when complete.</li>
		<li>Once all the air is evacuated, remove the chest tube while closing the wound using the purse string suture. Apply adhesive glue topically to cover the sternal incision.</li>
	</ol>
	</li>
	<li>Post operative care after surgery
	<ol>
		<li>Gradually wean the animal off the ventilator as skin incision is being closed. Ensure that the animal is able to spontaneously breathe and protect reflexes before disconnecting the animal from anesthesia equipment.</li>
		<li>Remove the endotracheal tube after confirming that animal is able to protect its airway. Cover the skin incision with sterile and non-adherent dressing embedded with antibiotic ointment to minimize surgical site infection.</li>
		<li>Continue to monitor vital signs including heart rate, respiratory rate, body temperature every 15 min until animal is able to hold its position without assistance.</li>
		<li>Ensure animal is not left unattended until able to lift and hold its head up and can stand without assistance. Administer meloxicam at a dose of 0.2 mg/kg via subcutaneous route before transporting the animal to the recovery unit.</li>
		<li>Transport the animal to the recovery unit when animal is stable. Keep the surgical site dressing on the incision until postoperative day 3. Replace the dressing if it becomes soiled.</li>
		<li>Continue to monitor the level of the pain, skin incision and overall well-being of the animal for the first 5 days after surgery. Administer half a dose of meloxicam (0.1 mg/kg) as needed once daily for breakthrough pain.</li>
		<li>Single house the animal for first 5 days after surgery while the incision(s) heal to reduce the risk of surgical site infection by another animal. Return the animal to group housing after 5 days.</li>
		<li>Report any complications or changes in the animal&#39;s condition (fever, ascites, weight loss, inappetence etc.) to the veterinarian or appropriate staff.</li>
	</ol>
	</li>
</ol>
3. Coronary angiography using femoral access
<ol>
	<li>Secure the animal on the operating table in the dorsal recumbency. Initiate mechanical ventilation at 10-15 breaths per min. Set oxygen at 2-4 L/min, isoflurane at 1% and 4%, as needed to maintain a deep plane of anesthesia.</li>
	<li>Place ECG leads on the animal&#39;s limb to monitor for heart rhythm. Evaluate the animal for the depth of anesthesia. Consider the animal deeply anesthetized when the eye or jaw reflex is absent.</li>
	<li>Clean the chest and neck area with povidone iodine scrub and then drape the animal with towels.</li>
	<li>Access the femoral artery via surgical cut-down and expose the femoral artery and vein. Make a 1-2 mm longitudinal incision with a no. 11 blade in femoral artery and cannulate the artery using an 11 Fr introducer sheath in the vessel lumen.</li>
	<li>After obtaining access, advance the catheter to perform coronary angiography to assess the anatomy patency of LIMA-LAD graft.</li>
</ol>

Adjunctive Exosome Therapy: Enhancing Myocardial Recovery Post-CABG Surgery

<ol>
	<li>Dai, H., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Global,+regional,+and+burden+of+ischaemic+heart+disease+and+its+attributable+risk+factors,+1990-2017:+results+from+the+Global+Burden+of+Disease+Study+2017.">Global, regional, and burden of ischaemic heart disease and its attributable risk factors, 1990-2017: results from the Global Burden of Disease Study 2017.</a> European heart journal. Quality of care &amp; clinical outcomes. 8 (1), 50-60 (2022).</li><li>Tsao, C. W., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Heart+Disease+and+Stroke+Statistics-2022+Update:+A+Report+From+the+American+Heart+Association.">Heart Disease and Stroke Statistics-2022 Update: A Report From the American Heart Association.</a> Circulation. 145 (8), e153-e639 (2022).</li><li>Rahimtoola, S. H. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=The+hibernating+myocardium.">The hibernating myocardium.</a> American Heart Journal. 117 (1), 211-221 (1989).</li><li>Canty, J. M., Fallavollita, J. A. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Hibernating+myocardium.">Hibernating myocardium.</a> Journal of Nuclear Cardiology. 12 (1), 104-119 (2005).</li><li>Page, B. J., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Revascularization+of+chronic+hibernating+myocardium+stimulates+myocyte+proliferation+and+partially+reverses+chronic+adaptations+to+ischemia.">Revascularization of chronic hibernating myocardium stimulates myocyte proliferation and partially reverses chronic adaptations to ischemia.</a> Journal of the American College of Cardiology. 65 (7), 684-697 (2015).</li><li>Aggarwal, R., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Persistent+diastolic+dysfunction+in+chronically+ischemic+hearts+following+coronary+artery+bypass+graft.">Persistent diastolic dysfunction in chronically ischemic hearts following coronary artery bypass graft.</a> The Journal of Thoracic and Cardiovascular Surgery. 165 (6), e269-e279 (2023).</li><li>Olsen, F. J., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Prognostic+Value+and+Interplay+Between+Myocardial+Tissue+Velocities+in+Patients+Undergoing+Coronary+Artery+Bypass+Grafting.">Prognostic Value and Interplay Between Myocardial Tissue Velocities in Patients Undergoing Coronary Artery Bypass Grafting.</a> The American Journal of Cardiology. 144, 37-45 (2021).</li><li>Virani, S. S. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Heart+Disease+and+Stroke+Statistics-2021+Update:+A+Report+From+the+American+Heart+Association.">Heart Disease and Stroke Statistics-2021 Update: A Report From the American Heart Association.</a> Circulation. 143 (8), e254-e743 (2021).</li><li>Hocum Stone, L., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Surgical+Swine+Model+of+Chronic+Cardiac+Ischemia+Treated+by+Off-Pump+Coronary+Artery+Bypass+Graft+Surgery.">Surgical Swine Model of Chronic Cardiac Ischemia Treated by Off-Pump Coronary Artery Bypass Graft Surgery.</a> Journal of Visualized Experiments:JoVE. (133), e57229 (2018).</li><li>White, F. C., Carroll, S. M., Magnet, A., Bloor, C. M. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Coronary+collateral+development+in+swine+after+coronary+artery+occlusion.">Coronary collateral development in swine after coronary artery occlusion.</a> Circulation Research. 71 (6), 1490-1500 (1992).</li><li>Righetti, A., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Interventricular+septal+motion+and+left+ventricular+function+after+coronary+bypass+surgery:+evaluation+with+echocardiography+and+radionuclide+angiography.">Interventricular septal motion and left ventricular function after coronary bypass surgery: evaluation with echocardiography and radionuclide angiography.</a> The American Journal of Cardiology. 39 (3), 372-377 (1977).</li><li>Hocum Stone, L. L., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Recovery+of+hibernating+myocardium+using+stem+cell+patch+with+coronary+bypass+surgery.">Recovery of hibernating myocardium using stem cell patch with coronary bypass surgery.</a> The Journal of Thoracic and Cardiovascular Surgery. 62 (1), e3-e16 (2021).</li><li>Puigserver, P., Spiegelman, B. M. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Peroxisome+proliferator-activated+receptor-gamma+coactivator+1+alpha+(PGC-1+alpha):+transcriptional+coactivator+and+metabolic+regulator.">Peroxisome proliferator-activated receptor-gamma coactivator 1 alpha (PGC-1 alpha): transcriptional coactivator and metabolic regulator.</a> Endocrine Reviews. 24 (1), 78-90 (2003).</li><li>Henning, R. J. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Cardiovascular+Exosomes+and+MicroRNAs+in+Cardiovascular+Physiology+and+Pathophysiology.">Cardiovascular Exosomes and MicroRNAs in Cardiovascular Physiology and Pathophysiology.</a> Journal of Cardiovascular Translational Research. 14 (2), 195-212 (2021).</li><li>Chen, Y., Liu, Y., Dorn, G. W. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=2nd.+Mitochondrial+fusion+is+essential+for+organelle+function+and+cardiac+homeostasis.">2nd. Mitochondrial fusion is essential for organelle function and cardiac homeostasis.</a> Circulation Research. 109 (12), 1327-1331 (2011).</li><li>Pittenger, M. F., Martin, B. J. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Mesenchymal+stem+cells+and+their+potential+as+cardiac+therapeutics.">Mesenchymal stem cells and their potential as cardiac therapeutics.</a> Circulation Research. 95 (1), 9-20 (2004).</li><li>Campos-Silva, C., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=High+sensitivity+detection+of+extracellular+vesicles+immune-captured+from+urine+by+conventional+flow+cytometry.">High sensitivity detection of extracellular vesicles immune-captured from urine by conventional flow cytometry.</a> Scientific Reports. 9 (1), 2042 (2019).</li><li>Hocum Stone, L. L., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Magnetic+resonance+imaging+assessment+of+cardiac+function+in+a+swine+model+of+hibernating+myocardium+3+months+following+bypass+surgery.">Magnetic resonance imaging assessment of cardiac function in a swine model of hibernating myocardium 3 months following bypass surgery.</a> The Journal of Thoracic and Cardiovascular Surgery. 153 (3), 582-590 (2017).</li><li>Stone, L. L. H., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Mitochondrial+Respiratory+Capacity+is+Restored+in+Hibernating+Cardiomyocytes+Following+Co-Culture+with+Mesenchymal+Stem+Cells.">Mitochondrial Respiratory Capacity is Restored in Hibernating Cardiomyocytes Following Co-Culture with Mesenchymal Stem Cells.</a> Cell Medicine. 11, 2155179019834938 (2019).</li><li>Lamy, A., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Skeletonized+vs+Pedicled+Internal+Mammary+Artery+Graft+Harvesting+in+Coronary+Artery+Bypass+Surgery:+A+Post+Hoc+Analysis+From+the+COMPASS+Trial.">Skeletonized vs Pedicled Internal Mammary Artery Graft Harvesting in Coronary Artery Bypass Surgery: A Post Hoc Analysis From the COMPASS Trial.</a> JAMA Cardiology. 6 (9), 1042-1049 (2021).</li><li>Shim, J. K., Choi, Y. S., Yoo, K. J., Kwak, Y. L. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Carbon+dioxide+embolism+induced+right+coronary+artery+ischaemia+during+off-pump+obtuse+marginalis+artery+grafting.">Carbon dioxide embolism induced right coronary artery ischaemia during off-pump obtuse marginalis artery grafting.</a> European Journal of Cardio-Thoracic Surgery. 36 (3), 598-599 (2009).</li><li>Aklog, L. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Future+technology+for+off-pump+coronary+artery+bypass+(OPCAB).">Future technology for off-pump coronary artery bypass (OPCAB).</a> Seminars in Thoracic and Cardiovascular Surgery. 15 (1), 92-102 (2003).</li><li>Hou, D., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Radiolabeled+cell+distribution+after+intramyocardial,+intracoronary,+and+interstitial+retrograde+coronary+venous+delivery:+implications+for+current+clinical+trials.">Radiolabeled cell distribution after intramyocardial, intracoronary, and interstitial retrograde coronary venous delivery: implications for current clinical trials.</a> Circulation. 112 (9 Suppl), I150-I156 (2005).</li><li>Gallet, R., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Exosomes+secreted+by+cardiosphere-derived+cells+reduce+scarring,+attenuate+adverse+remodelling,+and+improve+function+in+acute+and+chronic+porcine+myocardial+infarction.">Exosomes secreted by cardiosphere-derived cells reduce scarring, attenuate adverse remodelling, and improve function in acute and chronic porcine myocardial infarction.</a> European Heart Journal. 38 (3), 201-211 (2017).</li></ol>

The authors have nothing to disclose.

This study presents the first porcine model of chronically ischemic myocardium, in which it was shown that treatment with an MSC-derived exosome laden collagen patch during surgical revascularization recovers diastolic and systolic function upon inotropic stimulation potentially by targeting mitochondrial recovery. Previously, it was demonstrated that in a large animal model of HIB the diastolic and systolic function, as measured by cardiac MRI, remains impaired and only slightly improves with revascularization without c...

Globally, severe CAD affects over a hundred million patients, and although the mortality rate has decreased, it remains one of the leading causes of death1,2. CAD has a wide clinical spectrum from myocardial infarction (MI) to ischemia with preserved viability. Most pre-clinical research focuses on MI, characterized by the presence of infarcted tissue as it is possible to study in small and large animal models. However, that model does not address patients with preserved viability and amenable to revascularization. Most patients undergoing CABG have decreased blood supply and limited function while maintaining variability in contractile reserve and viability3. Without treatment, these patients can progress to advanced heart failure and sudden death, especially during increased workload4. Among these patients, coronary artery bypass graft (CABG) is an effective therapy but may not result in complete functional recovery5. Importantly, diastolic dysfunction, which is a marker for worse clinical outcomes, fails to recover after revascularization suggesting the need for novel adjuvant therapies during CABG6,7. Currently, there are no clinically available adjuvant interventions used with CABG to restore cardiomyocytes to full functional capacity. This is a major therapeutic gap given that many patients progress to advanced heart failure despite appropriate revascularization8.
An innovative porcine model of chronic myocardial ischemia that is amenable to CABG, to mimic clinical CAD experience was created9. Swine provide a good model of heart disease over other large animals as they do not have epicardial bridging collaterals so stenosis of the LAD alone results in regional ischemia10. In this study, 16-week-old female Yorkshire-Landrace pigs were used. In this model, the LAD was revascularized with off-pump CABG using the left internal mammary artery (LIMA) graft (Supplementary Table 1). Percutaneous coronary intervention (PCI) is not possible to open the stenosis as the constrictor is a rigid device. Cardiac magnetic resonance imaging (MRI) is used to assess global and regional function, coronary anatomy, and tissue viability. Cardiac MRI analysis showed diastolic function, characterized by peak filling rate (PFR) remains impaired despite CABG6. The mechanism of diastolic dysfunction likely relates to impaired mitochondrial bioenergetics and collagen formation in HIB that persist following CABG11.
Mesenchymal stem cells (MSC) provide therapeutic signaling through exosomes to improve myocardial recovery when applied during CABG. In this swine model and parallel in vitro studies, it was shown that placement of an epicardial MSC vicryl patch during CABG recovers contractile function with increase in key mitochondrial proteins namely PGC-1&#945;12, an important regulator of mitochondrial energy metabolism13. The in vitro model allowed us to investigate the signaling mechanism of MSCs on impaired mitochondrial function. Exosomes are secreted stable microvesicles (50-150 nm) that contain protein or nucleic acids including microRNA (miRNA)14. Recent in vitro data suggest that MSC-derived exosomes are an important signaling mechanism necessary for recovery of mitochondrial respiration.
Stem cell derived exosomes are promising adjunctive therapeutics as they are readily accessible, can be commercially produced, and lack ethical conflicts. In consideration of clinical translation, a collagen patch embedded with MSC-derived exosomes was created that can be surgically sutured to the hibernating region of myocardium. It was demonstrated that there is sustained delivery of exosomes using this patch and it provides a cell-free regenerative therapy with paracrine signaling mechanism that targets mitochondrial recovery and enhance mitochondrial biogenesis15. This procedure provides the pre-clinical model to study the impact of MSC-derived therapies to improve cardiac function by means of enhancing mitochondrial function and reducing inflammation at the time of revascularization and reverse the myocyte adaptations to chronic ischemia.
In this study, a surgical method of off-pump CABG using LIMA to LAD anastomosis to bypass the area of proximal LAD stenosis mimicking the standard treatment for patients with CAD is shown. As an adjunctive therapy with CABG, the surgical application of MSC-derived exosome embedded collagen patch on the ischemic region of the myocardium was demonstrated. This surgical model can be used to study the physiologic responses to the paracrine effect seen with use of an exosome patch as well as the molecular mechanisms of recovery.

<table border="1" fo:keep-together.within-page="1" fo:keep-with-next.within-page="always">
	<tbody>
		<tr>
			<td>5 Ethibond</td>
			<td>Ethicon</td>
			<td>MG46G</td>
			<td>Suture</td>
		</tr>
		<tr>
			<td># 40 clipper blade</td>
			<td>Oster</td>
			<td>078919-016-701</td>
			<td>Remove hair from surgery sites</td>
		</tr>
		<tr>
			<td>0 Vicryl</td>
			<td>Ethicon</td>
			<td>J208H</td>
			<td>Suture</td>
		</tr>
		<tr>
			<td>1 mL Syringe</td>
			<td>Medtronic/Covidien</td>
			<td>1188100777</td>
			<td>Administer injectable agents</td>
		</tr>
		<tr>
			<td>1&#34; medical tape</td>
			<td>Medline</td>
			<td>MMM15271Z</td>
			<td>Secure wound dressing and IV catheters</td>
		</tr>
		<tr>
			<td>1000mL 0.9% Sodium chloride</td>
			<td>Baxter</td>
			<td>2B1324X</td>
			<td>IV replacement fluid</td>
		</tr>
		<tr>
			<td>12 mL Syringe</td>
			<td>Medtronic/Covidien</td>
			<td>8881512878</td>
			<td>Administer injectable agents</td>
		</tr>
		<tr>
			<td>18 ga needles</td>
			<td>BD</td>
			<td>305185</td>
			<td>Administration of injectable agents</td>
		</tr>
		<tr>
			<td>20 ga needles</td>
			<td>BD</td>
			<td>305175</td>
			<td>Administration of injectable agents</td>
		</tr>
		<tr>
			<td>20 mL Syringe</td>
			<td>Medtronic/Covidien</td>
			<td>8881520657</td>
			<td>Administer injectable agents</td>
		</tr>
		<tr>
			<td>2-0 Vicryl</td>
			<td>Ethicon</td>
			<td>J317H</td>
			<td>Suture</td>
		</tr>
		<tr>
			<td>250 mL 0.9% saline</td>
			<td>Baxter</td>
			<td>&#160;UE1322D</td>
			<td>Replacement IV Fluid</td>
		</tr>
		<tr>
			<td>3 mL Syinge</td>
			<td>Medtronic/Covidien</td>
			<td>1180300555</td>
			<td>Administer injectable agents</td>
		</tr>
		<tr>
			<td>3-0 Vicryl</td>
			<td>Ethicon</td>
			<td>VCP824G</td>
			<td>Suture</td>
		</tr>
		<tr>
			<td>36&#8221; Pressure monitoring tubing</td>
			<td>Smith&#8217;s Medical</td>
			<td>MX563</td>
			<td>Connect art. Line&#160; to transducer</td>
		</tr>
		<tr>
			<td>4.0 mm ID endotracheal tube</td>
			<td>Medline</td>
			<td>DYND43040</td>
			<td>Establish airway for Hibernation</td>
		</tr>
		<tr>
			<td>4-0 Tevdek II Strands</td>
			<td>Deknatel</td>
			<td>7-922</td>
			<td>Suture to secure constrictor around LAD</td>
		</tr>
		<tr>
			<td>48&#8221; Pressure monitoring tubing</td>
			<td>Smith&#8217;s Medical</td>
			<td>MX564</td>
			<td>Connect art. Line&#160; to transducer</td>
		</tr>
		<tr>
			<td>500mL 0.9% Sodium chloride</td>
			<td>Baxter</td>
			<td>2B1323Q</td>
			<td>Drug delivery, Provide mist for Blower Mister</td>
		</tr>
		<tr>
			<td>6&#160; mL Syringe</td>
			<td>Medtronic/Covidien</td>
			<td>1180600777</td>
			<td>Administer injectable agents</td>
		</tr>
		<tr>
			<td>6.0 mm ID endotracheal tube</td>
			<td>Mallinckrodt</td>
			<td>86049</td>
			<td>Establish airway for Revasc,MRI and Termination</td>
		</tr>
		<tr>
			<td>6.5 mm ID endotracheal tube</td>
			<td>Medline</td>
			<td>DYND43065</td>
			<td>Establish airway for Revasc,MRI and Termination</td>
		</tr>
		<tr>
			<td>6&#8221; pressure tubing line</td>
			<td>Smith&#8217;s Medical</td>
			<td>MX560</td>
			<td>Collect bone marrow</td>
		</tr>
		<tr>
			<td>60 mL Syringe</td>
			<td>Medtronic/Covidien</td>
			<td>8881560125</td>
			<td>Administer injectable agents</td>
		</tr>
		<tr>
			<td>7.0 mm ID endotracheal tube</td>
			<td>Medline</td>
			<td>DYND43070</td>
			<td>Establish airway for Revasc,MRI and Termination</td>
		</tr>
		<tr>
			<td>7-0 Prolene</td>
			<td>Ethicon</td>
			<td>M8702</td>
			<td>Suture</td>
		</tr>
		<tr>
			<td>Advanced DMEM (1X)</td>
			<td>ThermoFisher Scientific</td>
			<td>12491023</td>
			<td></td>
		</tr>
		<tr>
			<td>Alcohol Prep pads</td>
			<td>MedSource</td>
			<td>MS-17402</td>
			<td>Skin disinfectant</td>
		</tr>
		<tr>
			<td>Amicon Ultra-15 Centrifugal Filter Unit</td>
			<td>Millipore Sigma</td>
			<td>UFC910024</td>
			<td></td>
		</tr>
		<tr>
			<td>Anesthesia Machine</td>
			<td>Drager</td>
			<td>Fabious Trio</td>
			<td>maintains general anesthesia</td>
		</tr>
		<tr>
			<td>Anesthesia Machine + ventilator</td>
			<td>DRE Drager- Fabius Tiro</td>
			<td>DRE0603FT</td>
			<td>Deliver Oxygen and inhalant to patient</td>
		</tr>
		<tr>
			<td>Anesthesia Monitor</td>
			<td>Phillips&#160; Intellivue</td>
			<td>MP70</td>
			<td>Multiparameter for patient safety</td>
		</tr>
		<tr>
			<td>Arterial Line Kit</td>
			<td>Arrow</td>
			<td>ASK-04510-HF</td>
			<td>Femoral catheter for blood pressure monitoring</td>
		</tr>
		<tr>
			<td>Artificial Tears</td>
			<td>Rugby</td>
			<td>0536-1086-91</td>
			<td>Lubricate eyes to prevent corneal drying</td>
		</tr>
		<tr>
			<td>Bair Hugger</td>
			<td>3M</td>
			<td>Model 505</td>
			<td>Patient Warming system</td>
		</tr>
		<tr>
			<td>Basic pack</td>
			<td>Medline</td>
			<td>DYNJP1000</td>
			<td>Sterile drapes and table cover</td>
		</tr>
		<tr>
			<td>Blood Collection Tubes- green top</td>
			<td>Fisher Scientific</td>
			<td>02-689-7</td>
			<td>Collect microsphere blood samples</td>
		</tr>
		<tr>
			<td>Blower Mister Kit</td>
			<td>Medtronic/Covidien</td>
			<td>22120</td>
			<td>Clears surgical field for vessel anastomosis</td>
		</tr>
		<tr>
			<td>BODIPY TR Ceramide</td>
			<td>ThermoFisher Scientific</td>
			<td>D7540</td>
			<td></td>
		</tr>
		<tr>
			<td>Bone marrow needle- 25mm 15 ga IO needle</td>
			<td>Vidacare</td>
			<td>9001-VC-005</td>
			<td>Collect bone marrow</td>
		</tr>
		<tr>
			<td>Bone Wax</td>
			<td>Medline</td>
			<td>ETHW31G</td>
			<td>Hemostasis of cut bone</td>
		</tr>
		<tr>
			<td>Bovie Cautery hand piece</td>
			<td>Covidien</td>
			<td>E2516</td>
			<td>Hemostasis</td>
		</tr>
		<tr>
			<td>Bupivicaine</td>
			<td>Pfizer</td>
			<td>00409-1161-01</td>
			<td>Local Anesthetic</td>
		</tr>
		<tr>
			<td>Buprenorphine 0.3 mg/mL</td>
			<td>Sigma Aldrich</td>
			<td>B9275</td>
			<td>Pre operative Analgesic for survivial procedures</td>
		</tr>
		<tr>
			<td>Cell Scrapers</td>
			<td>Corning</td>
			<td>353085</td>
			<td></td>
		</tr>
		<tr>
			<td>Cephazolin 1 gr</td>
			<td>Pfizer</td>
			<td>00409-0805-01</td>
			<td>Antibiotic</td>
		</tr>
		<tr>
			<td>Chest Tube</td>
			<td>Covidien</td>
			<td>8888561043</td>
			<td>Evacuates air from chest cavity</td>
		</tr>
		<tr>
			<td>Cloroprep</td>
			<td>Becton Dickenson</td>
			<td>260815</td>
			<td>Surgical skin prep</td>
		</tr>
		<tr>
			<td>Corning bottle-top vacuum Filter System (500mL)</td>
			<td>Millipore Sigma</td>
			<td>430758</td>
			<td></td>
		</tr>
		<tr>
			<td>CPT tube</td>
			<td>BD</td>
			<td>362753</td>
			<td>MSC isolation from bone marrow</td>
		</tr>
		<tr>
			<td>Delrin Constrictor</td>
			<td>U of MN</td>
			<td>Custom made</td>
			<td>Creates stenosis of LAD</td>
		</tr>
		<tr>
			<td>Dermabond</td>
			<td>Ethicon</td>
			<td>DNX12</td>
			<td>Skin adhesive</td>
		</tr>
		<tr>
			<td>DMEM (1X) Dulbecco&#39;s Modified Eagle Medium, HEPES</td>
			<td>ThermoFisher Scientific</td>
			<td>12430062</td>
			<td></td>
		</tr>
		<tr>
			<td>Dobutamine 12.5 mg/mL</td>
			<td>Pfizer</td>
			<td>00409-2344-01</td>
			<td>Increases blood pressure and heart rate during the second microsphere blood collection</td>
		</tr>
		<tr>
			<td>ECG Pads</td>
			<td>DRE</td>
			<td>1496</td>
			<td>Monitor heart rhythm</td>
		</tr>
		<tr>
			<td>Exosome-Depleted FBS</td>
			<td>ThermoFisher Scientific</td>
			<td>A2720801</td>
			<td></td>
		</tr>
		<tr>
			<td>Falcon Disposable Polystyrene Serological Pipets, Sterile, 10mL</td>
			<td>Fisher Scientific</td>
			<td>13-675-20</td>
			<td></td>
		</tr>
		<tr>
			<td>Femoral and carotid introducer</td>
			<td>Cordis- J&#38;J</td>
			<td>504606P</td>
			<td>femoral and carotis cannulas</td>
		</tr>
		<tr>
			<td>Fetal Bovine Serum, Heat Inactivated, Gibco FBS</td>
			<td>ThermoFisher Scientific</td>
			<td>16140089</td>
			<td></td>
		</tr>
		<tr>
			<td>Flo-thru 1.0</td>
			<td>Baxter</td>
			<td>FT-12100</td>
			<td>used to anastomos LIMA to L</td>
		</tr>
		<tr>
			<td>Flo-thru 1.25</td>
			<td>Baxter</td>
			<td>FT-12125</td>
			<td>FT-12125</td>
		</tr>
		<tr>
			<td>Flo-thru 1.5</td>
			<td>Baxter</td>
			<td>FT-12150</td>
			<td>FT-12150</td>
		</tr>
		<tr>
			<td>Flo-thru 2.0</td>
			<td>Baxter</td>
			<td>FT-12200</td>
			<td>FT-12200</td>
		</tr>
		<tr>
			<td>GlutaMAX Supplement</td>
			<td>ThermoFisher Scientific</td>
			<td>35050061</td>
			<td></td>
		</tr>
		<tr>
			<td>Hair Clipper</td>
			<td>Oster</td>
			<td>078566-011-002</td>
			<td>Remove hair from surgery sites</td>
		</tr>
		<tr>
			<td>Helistat collagen sponge</td>
			<td>McKesson</td>
			<td>570973 1690ZZ</td>
			<td>Sponge for embedding exosomes</td>
		</tr>
		<tr>
			<td>Heparin</td>
			<td>Pfizer</td>
			<td>&#160;0409-2720-03</td>
			<td>anticoaggulant</td>
		</tr>
		<tr>
			<td>Histology Jars</td>
			<td>Fisher Scientific</td>
			<td>316-154</td>
			<td>Formalin for tissue samples</td>
		</tr>
		<tr>
			<td>HyClone Characterized Fetal Bovine Serum (FBS)</td>
			<td>Cytiva</td>
			<td>SH30071.03</td>
			<td></td>
		</tr>
		<tr>
			<td>Hypafix</td>
			<td>BSN Medical</td>
			<td>4210</td>
			<td>Secure wound dressing and IV catheters</td>
		</tr>
		<tr>
			<td>Isoflurane</td>
			<td>Sigma Aldrich</td>
			<td>CDS019936</td>
			<td>General Anesthestic- Inhalant</td>
		</tr>
		<tr>
			<td>IV Tubing for Blower Mister</td>
			<td>Carefusion</td>
			<td>42493E</td>
			<td>Adapts to IV Fluids for Blower/Mister</td>
		</tr>
		<tr>
			<td>Jelco 18 ga IV catheter</td>
			<td>Smiths medical</td>
			<td>4054</td>
			<td>IV access in Revasc, MRI and Term</td>
		</tr>
		<tr>
			<td>Lidocaine 2%</td>
			<td>Pfizer</td>
			<td>00409-4277-01</td>
			<td>Local Anesthetic/ antiarrthymic</td>
		</tr>
		<tr>
			<td>Ligaclips</td>
			<td>Ethicon</td>
			<td>MSC20</td>
			<td>Surgical Staples for LIMA takedown</td>
		</tr>
		<tr>
			<td>Long blade for laryngoscope</td>
			<td>DRE</td>
			<td>12521</td>
			<td>Allows for visualization of trachea for intubation</td>
		</tr>
		<tr>
			<td>Meloxicam 5 mg/mL</td>
			<td>Boehringer Ingelheim</td>
			<td>141-219</td>
			<td>Post operative Analgesic</td>
		</tr>
		<tr>
			<td>Microsphere pump</td>
			<td></td>
			<td></td>
			<td>Collect blood samples from femoral introducer</td>
		</tr>
		<tr>
			<td>Monopolar Cautery</td>
			<td>Covidien</td>
			<td>Valleylab&#8482; FT10</td>
			<td>Hemostasis</td>
		</tr>
		<tr>
			<td>Nanosight NS 300</td>
			<td>Malvern Panalytical</td>
			<td>MAN0541-03-EN</td>
			<td></td>
		</tr>
		<tr>
			<td>NTA 3.1.54 software</td>
			<td>Malvern Panalytical</td>
			<td>MAN0520-01-EN-00</td>
			<td></td>
		</tr>
		<tr>
			<td>OPVAC Synergy II</td>
			<td>Terumo Cardiovascular System</td>
			<td>401-230</td>
			<td>Heart positioner and Stabilizer</td>
		</tr>
		<tr>
			<td>Oxygen Tank E cylinder</td>
			<td>various</td>
			<td>various</td>
			<td>Used for Blower Mister if anesthesia machine doesn&#39;t have auxiliary flow meter</td>
		</tr>
		<tr>
			<td>PBS, pH 7.2</td>
			<td>ThermoFisher Scientific</td>
			<td>20012050</td>
			<td></td>
		</tr>
		<tr>
			<td>Penicillin-Streptomycin-Neomycin (PSN) Antibiotic Mixture</td>
			<td>ThermoFisher Scientific</td>
			<td>15640055</td>
			<td></td>
		</tr>
		<tr>
			<td>Pigtail 145 catheter 6 French</td>
			<td>Boston Scientific</td>
			<td>08641-41</td>
			<td>Measure LV pressures</td>
		</tr>
		<tr>
			<td>Pressure Transducer</td>
			<td>various</td>
			<td>Must adapt to anesthesia monitor</td>
			<td>Monitor direct arterial pressures</td>
		</tr>
		<tr>
			<td>Propofol</td>
			<td>Diprivan</td>
			<td>269-29</td>
			<td>Induction agent</td>
		</tr>
		<tr>
			<td>Roncuronium</td>
			<td>Mylan</td>
			<td>67457-228-05</td>
			<td>Neuromuscular blocking agent</td>
		</tr>
		<tr>
			<td>SR Buprenorphine 10 mg/mL</td>
			<td>Abbott Labs</td>
			<td>NADA 141-434</td>
			<td>Post operative Analgesic</td>
		</tr>
		<tr>
			<td>Sterile Saline 20 mL</td>
			<td>Fisher Scientific</td>
			<td>20T700220</td>
			<td>Flush for IV catheters</td>
		</tr>
		<tr>
			<td>Sternal Saw/ Necropsy Saw</td>
			<td>Thermo Fisher</td>
			<td>812822</td>
			<td>Used to open chest cavity</td>
		</tr>
		<tr>
			<td>Stop Cocks</td>
			<td>Smith Medical</td>
			<td>MX5311L</td>
			<td>2 to connect to pig tail</td>
		</tr>
		<tr>
			<td>Succinylcholine 20 mg/mL</td>
			<td>Pfizer</td>
			<td>00409-6629-02</td>
			<td>Neuromuscular blocking agent</td>
		</tr>
		<tr>
			<td>Suction&#160; tubing</td>
			<td>Medline</td>
			<td>DYND50223</td>
			<td></td>
		</tr>
		<tr>
			<td>Suction Container</td>
			<td>Medline</td>
			<td>DYNDCL03000</td>
			<td></td>
		</tr>
		<tr>
			<td>Surgery pack with chest retractor</td>
			<td>various</td>
			<td>See pack list</td>
			<td>Femoral cut down and median sternotomy</td>
		</tr>
		<tr>
			<td>Surgical Instruments</td>
			<td>various</td>
			<td>See pack list</td>
			<td>Femoral and carotid cutdowns and sternotomy</td>
		</tr>
		<tr>
			<td>Surgical Spring Clip</td>
			<td>Applied Medical</td>
			<td>A1801</td>
			<td>Clamp end of LIMA after takedown</td>
		</tr>
		<tr>
			<td>Syringe pump</td>
			<td>Harvard</td>
			<td></td>
			<td>Delivers IV Dobutamine infusion</td>
		</tr>
		<tr>
			<td>SYTO RNASelect Green Fluorescent cell Stain - 5 mM Solution in DMSO</td>
			<td>Millipore Sigma</td>
			<td>S32703</td>
			<td></td>
		</tr>
		<tr>
			<td>Telazol 100 mg/mL</td>
			<td>Fort Dodge</td>
			<td>01L60030</td>
			<td>Pre operative Sedative</td>
		</tr>
		<tr>
			<td>Telpha pad</td>
			<td>Covidien</td>
			<td>2132</td>
			<td>Sterile wound dressing</td>
		</tr>
		<tr>
			<td>Timer</td>
			<td></td>
			<td></td>
			<td>Time collection of blood samples</td>
		</tr>
		<tr>
			<td>Total Exosome Isolation Reagent (from cell culture media)</td>
			<td>ThermoFisher Scientific</td>
			<td>4478359</td>
			<td></td>
		</tr>
		<tr>
			<td>TPP Tissue Culture Flask, T75, Filter Cap w/ 0.22uM PTFE</td>
			<td>ThermoFisher Scientific</td>
			<td>TP90076</td>
			<td></td>
		</tr>
		<tr>
			<td>Triple Antibiotic Ointment</td>
			<td>Johnson &#38; Johnson</td>
			<td>23734</td>
			<td>Topical over wound</td>
		</tr>
		<tr>
			<td>Vicryl mesh</td>
			<td>Ethicon</td>
			<td>VKML</td>
			<td>Patch for epicardial cell application</td>
		</tr>
		<tr>
			<td>Vortex</td>
			<td></td>
			<td></td>
			<td>Mix microspheres</td>
		</tr>
		<tr>
			<td>Xylazine 100 mg/mL</td>
			<td>Vedco</td>
			<td>468RX</td>
			<td>Pre operative Sedative/ analgesic</td>
		</tr>
	</tbody>
</table>

surgical porcine model of chronic myocardial ischemia treated by exosome-laden collagen patch and off-pump coronary artery bypass graft

Chronic myocardial ischemia resulting from progressive coronary artery stenosis leads to hibernating myocardium (HIB), defined as myocardium that adapts to reduced oxygen availability by reducing metabolic activity, thereby preventing irreversible cardiomyocyte injury and infarction. This is distinct from myocardial infarction, as HIB has the potential for recovery with revascularization. Patients with significant coronary artery disease (CAD) experience chronic ischemia, which puts them at risk for heart failure and sudden death. The standard surgical intervention for severe CAD is coronary artery bypass graft surgery (CABG), but it has been shown to be an imperfect therapy, yet no adjunctive therapies exist to recover myocytes adapted to chronic ischemia. To address this gap, a surgical model of HIB using porcine that is amenable to CABG and mimics the clinical scenario was used. The model involves two surgeries. The first operation involves implanting a 1.5 mm rigid constrictor on the left anterior descending (LAD) artery. As the animal grows, the constrictor gradually causes significant stenosis resulting in reduced regional systolic function. Once the stenosis reaches 80%, the myocardial flow and function are impaired, creating HIB. An off-pump CABG is then performed with the left internal mammary artery (LIMA) to revascularize the ischemic region. The animal recovers for one month to allow for optimal myocardial improvement prior to sacrifice. This allows for physiologic and tissue studies of different treatment groups. This animal model demonstrates that cardiac function remains impaired despite CABG, suggesting the need for novel adjunctive interventions. In this study, a collagen patch embedded with mesenchymal stem cell (MSC)-derived exosomes was developed, which can be surgically applied to the epicardial surface distal to LIMA anastomosis. The material conforms to the epicardium, is absorbable, and provides the scaffold for the sustained release of signaling factors. This regenerative therapy can stimulate myocardial recovery that does not respond to revascularization alone. This model translates to the clinical arena by providing means of physiological and mechanistic explorations regarding recovery in HIB.

Author Spotlight: Enhancing Coronary Artery Revascularization

Surgical Porcine Model of Chronic Myocardial Ischemia Treated by Exosome-laden Collagen Patch and Off-pump Coronary Artery Bypass Graft

The overall goal of this surgical procedure is to create a surgical model of coronary artery revascularization using LIMA to LAD bypass, and the use of exosome-laden collagen patch as an adjunct to demonstrate physiological improvement in cardiac function. Our in-vivo model is a single-vessel model that does not include any comorbidities, which is not representative of the typical clinical situation for patients undergoing treatment for multi-vessel disease. However, despite this limitation, our model has consistently produced reliable results and has maintained low mortality rates.We developed a clinically relevant adjuvant therapy to be used during CABG and aim to understand the cellular mechanisms driving the myocardial functional improvement in chronic myocardial ischemia. Complete recovery of ischemic tissue appears to hinge on restoration of mitochondrial capabilities and reduced inflammation;representing a novel area of study.

Following revascularization, coronary angiography is performed to assess for LAD stenosis (greater than 80%) and patency of the LIMA-LAD graft (Figure 1). Four weeks following the revascularization surgery and placement of the exosome-laden collagen patch, cardiac MRI is performed to assess for systolic and diastolic function of the heart at rest and under stress using low-dose dobutamine infusion at 5&#181;g/kg/min. Systolic function is analyzed by measuring wall thickness percentage (wall ...

Watch this Scientific Journal Video about Surgical Porcine Model of Chronic Myocardial Ischemia Treated by Exosome-laden Collagen Patch and Off-pump Coronary Artery Bypass Graft at JoVE.com

This study presents a surgical porcine model of chronic myocardial ischemia due to progressive coronary artery stenosis, resulting in impaired cardiac function without infarction. Following ischemia, animals undergo off-pump coronary artery bypass graft with epicardial placement of stem cells-derived exosomes-laden collagen patch. This adjunctive therapy improves myocardial function and recovery.

Chronic myocardial ischemia resulting from progressive coronary artery stenosis leads to hibernating myocardium (HIB), defined as myocardium that adapts ...

surgical-porcine-model-chronic-myocardial-ischemia-treated-exosome

Research

JoVE Journal

Medicine

496 Views.  University of Minnesota. The overall goal of this surgical procedure is to create a surgical model of coronary artery revascularization using LIMA to LAD bypass, and the use of exosome-laden collagen patch as an adjunct to demonstrate physiological improvement in cardiac function. Our in-vivo model is a single-vessel model that does not include any comorbidities, which is not representative of the typical clinical situation for patients undergoing treatment for multi-vessel disease. However, despite this limitation, ...

Video: Author Spotlight: Enhancing Coronary Artery Revascularization

Off-Pump Coronary Artery Bypass Graft Surgery for Preparing a Porcine Model of Chronic Myocardial Ischemia

To begin, position the anesthetized and intubated animal on its back and cover it with sterile towels. Use monopolar electrocautery to make a 20 centimeter incision, extending from the sternal notch proximally down to the xiphoid process distally, and to incise layers of muscles, subcutaneous fat and connective tissue down to the sternum. Then carry out a medium sternotomy, employing an oscillating saw.For efficient visualization of the mediastinum, use a specialized chest retractor. Dissect adhesions using monopolar electrocautery or Metzenbaum scissors. Then expose LIMA by dissecting the parasternal muscle and fat.Next, start the dissection of the LIMA by elevating the left sternal border to ensure optimal visualization. Apply gentle traction to the adventitia and expose the arterial and venous branches of the LIMA. Employ blunt dissection using electrocautery tip to carefully separate it from the chest wall.Use hemo clips on the branches and cauterize the chest wall side of these branches. Then clip the distal end of the LIMA just before the point of bifurcation and divide the conduit. Secure the distal end with a freely tied 2-O silk suture.After preparing the proximal end for grafting, evaluate the flow quality manually by allowing the graft to bleed briefly. Now clamp the distal end of the LIMA conduit with an atraumatic bulldog clamp to prevent bleeding. Stabilize the left anterior descending, or LAD artery, using silicone retraction tape and a tissue stabilizer that's secured to the sternal retractor.Perform an arteriotomy in the LAD artery distal to the stenosis, using an 11 blade, and extend it with iris scissors. Position an appropriately sized coronary shunt in the LAD artery. Conduct the LIMA to LAD anastomosis using a 7-O running, non-absorbable suture in an off-pump bypass technique.Take a three millimeter exosome suspension and use a five milliliter syringe equipped with an 18 gauge needle to mix it. Then gradually pipette 1.5 milliliters of this suspension onto two absorbable collagen sponges, placed in a medium sized Petri dish. To target the hibernating region of the heart, place the exosome sponge upside down on the epicardium of the anterior septal region in the distribution of the LAD artery.Carefully arrange two sponges to fully cover the hibernating region. Use a polyglactin mesh on each collagen sponge to ensure proper coverage and sew the mesh onto the epicardium with fine 7-O interrupted sutures. Make a separate stab incision near the inferior aspect of the sternotomy incision and place the chest tube carefully on the anterior aspect of the heart.Approximate the sternum using non-absorbable sutures, employing a figure eight pattern. Close layers of muscle and skin using 2-O and 3-O absorbable sutures, respectively, following the standard procedure. After evacuating the chest cavity with a chest tube, seal the wound using a purse string suture.Once the wound is closed, remove the chest tube. At rest, the peak filling rate over end diastolic volume is compared among four animal groups. In low dose dobutamine infusion, the group with hibernating myocardium had a decrease in peak filling rate.The coronary artery bypass graft surgery group showed improvement, while the coronary artery bypass graft, plus mesenchymal stem cell group, saw a significant increase. MRI analysis revealed that coronary artery bypass graft, plus mesenchymal stem cell group does not alter regional systolic function at rest. However, under stress this group showed significant improvement in regional systolic function compared to coronary artery bypass graft.